US Patent Issued to The Institute of Cancer Research: Royal Cancer Hospital on April 22 for "Therapeutic compositions, combinations, and methods of use" (British Inventor)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,050, issued on April 22, was assigned to The Institute of Cancer Research: Royal Cancer Hospital (London).

"Therapeutic compositions, combinations, and methods of use" was invented by Udai Banerji (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods comprising administering a FAK inhibitor (e.g., VS-6063) in combination with a dual RAF/MEK inhibitor (e.g., CHS 126766) that are useful in the treatment of abnormal cell growth, such as cancer, in a subject such as humans."

The patent was filed on Jan. 18, 2024, under Application No. 18/416,354.

*For further information, including images, charts and tables, please vi...